Methods: Female adult Sprague-Dawley rats were treated with vehicle (0.2% saccharin) or methadone (30 mg/kg/day) two weeks prior to conception, throughout gestation and lactation. Adolescent offspring (postnatal days 35-45) underwent behavioural assessments, including open-field testing (OFT), novel object recognition (NOR) and rewarded T-maze alternation tasks. Furthermore, hippocampal BDNF protein levels were quantified.
Background: Maternal supplementation with ω-3 long chain polyunsaturated fatty acids (LCPUFAs) extends the length of pregnancy. We investigated whether an ω-3 LCPUFA supplementation strategy reduced the incidence of early preterm birth <34 weeks (EPTB), without increasing interventions for postterm pregnancies.
Methods: Women with singleton or multiple pregnancies were randomised to receive either fish oil capsules (900mg ω-3 LCPUFA/day) or vegetable oil capsules (with trace ω-3 LCPUFA) from <20 weeks. Supplementation ceased at 34 weeks or delivery, whichever occurred first, as a strategy to reduce post-term pregnancies. EPTB was the primary outcome; pregnancy and neonatal outcomes were also assessed.
Results: 5544 women were randomised. The incidence of EPTB between ω-3 LCPUFA supplemented women (61/2734, 2.25%) and controls (55/2752, 1.98%) did not differ (adjusted relative risk, ARR, 1.13, 95% CI 0.79-1.63; P = 0.50). There were no differences in interventions for post-term pregnancies, and no differences in pregnancy or neonatal outcomes except for an increased incidence of infants born very large for gestational age in ω-3 LCPUFA supplemented women compared with controls (ARR 1.30; 95% CI 1.02-1.65; P = 0.04). There were some interactions between ω-3 LCPUFA supplementation and multiplicity suggesting that supplementation does not benefit women with multiple pregnancies; in this regard supplementation was associated with a reduction in preterm birth in singleton pregnancies (ARR 0.81; P=0.04) .
Conclusions: Supplementation with ω-3 LCPUFA in pregnancy from <20 until 34 weeks' did not decrease EPTB, though did not increase interventions for post-term pregnancies. Benefits of ω-3 LCPUFA supplementation may be limited to singleton pregnancies.
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